These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8140085)

  • 1. [Psychotic disorders in Parkinson disease: value of clozapine].
    Courtet P; Abbar M; Monié J; Amphoux G; Castelnau D
    Presse Med; 1994 Jan; 23(2):99. PubMed ID: 8140085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of psychotic complications of Parkinson disease with clozapine].
    Ozsancak C; Auzou P; Ronzière T; Hannequin D; Augustin P
    Presse Med; 1997 Nov; 26(33):1599-602. PubMed ID: 9452762
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.
    Wagner ML; Defilippi JL; Menza MA; Sage JI
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple re-challenges for clozapine neutropenia in Parkinson's disease.
    Komaragiri A; Friedman JH
    Parkinsonism Relat Disord; 2016 Feb; 23():114-5. PubMed ID: 26717858
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine is beneficial for psychosis in Parkinson's disease.
    Kahn N; Freeman A; Juncos JL; Manning D; Watts RL
    Neurology; 1991 Oct; 41(10):1699-700. PubMed ID: 1922830
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
    Pintor L; Valldeoriola F; Baillés E; Martí MJ; Muñiz A; Tolosa E
    Clin Neuropharmacol; 2012; 35(2):61-6. PubMed ID: 22388466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-induced aplastic anemia in a patient with Parkinson's disease.
    Ziegenbein M; Steinbrecher A; Garlipp P
    Can J Psychiatry; 2003 Jun; 48(5):352. PubMed ID: 12866349
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease.
    Pinter MM; Helscher RJ
    J Neural Transm Park Dis Dement Sect; 1993; 5(2):135-46. PubMed ID: 8333909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
    Diraoui S; van Melick EJ; Jansen PA
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine therapeutic plunge in patient with Parkinson's disease.
    Greene P
    Lancet; 1995 May; 345(8958):1172-3. PubMed ID: 7723559
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine treatment of parkinsonism with psychosis.
    Lew MF; Waters CH
    J Am Geriatr Soc; 1993 Jun; 41(6):669-71. PubMed ID: 8505467
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic management of psychosis in the elderly: a critical review.
    Hoeh N; Gyulai L; Weintraub D; Streim J
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):213-8. PubMed ID: 14653429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis.
    Factor SA; Brown D; Molho ES; Podskalny GD
    Neurology; 1994 Mar; 44(3 Pt 1):544-6. PubMed ID: 8145929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychotic disorders in Parkinson's disease and dementia with Lewy bodies].
    Levin OS; Anikina MA; Shindriaeva NN; Zimniakova OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):82-8. PubMed ID: 21905342
    [No Abstract]   [Full Text] [Related]  

  • 19. Clozapine in treatment of Parkinson's disease.
    Jones KM; Stoukides CA
    Ann Pharmacother; 1992 Nov; 26(11):1386-7. PubMed ID: 1477443
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clozapine and olanzapine in the treatment of the psychotic disorders in Parkinson's disease].
    Chacón J
    Rev Neurol; 2004 Oct 1-15; 39(7):655-60. PubMed ID: 15490354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.